Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sofwave MedicalXTAE:SOFW 84 Days Payable is 128.37 as of Jun. 2026, which is 25% below its 10-year median of 171.50. GuruFocus rates XTAE:SOFW with a GF Score™ of 84/100 and a GF Value™ of ₪33.26 (Fairly Valued). The stock has 1 warning sign investors should review. Among 797 Medical Devices & Instruments companies, Sofwave Medical ranks better than 70.77% on this metric.
The historical rank and industry rank for Sofwave Medical's Days Payable or its related term are showing as below:
XTAE:SOFW'
s Days Payable Range Over the Past 10 Years
Min: 117.07 Med: 171.5 Max: 518.95
Current: 117.07
During the past 7 years, Sofwave Medical's highest Days Payable was 518.95. The lowest was 117.07. And the median was 171.50.
XTAE:SOFW's Days Payable is ranked better than 70.77% of 797
companies
in the Medical Devices & Instruments industry
Industry Median: 69.48
vs XTAE:SOFW: 117.07
Sofwave Medical's Days Payable
increased
from Jun. 2025 (122.19) to Jun. 2026 (128.37).
It may suggest that Sofwave Medicaldelayed paying its suppliers.
The historical data trend for Sofwave Medical's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XTAE:SOFW vs ABT, SYK, MDT: Days Payable Comparison
For the Medical Devices subindustry, Sofwave Medical's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sofwave Medical Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sofwave Medical's Days Payable distribution charts can be found below:
* The bar in red indicates where Sofwave Medical's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Sofwave Medical's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sofwave Medical (XTAE:SOFW) has a Days Payable of 128.37 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Sofwave Medical and its competitors. This is 25% below median its historical median of 171.50. Over the past decade, Sofwave Medical's Days Payable has ranged from 117.07 to 518.95. According to the industry distribution chart, Sofwave Medical ranks #233 out of 797 companies in the Medical Devices & Instruments industry, placing it in the top 29.2%.
Is Sofwave Medical's Days Payable too high?
Sofwave Medical's current Days Payable of 128.37 is 25% below median its 10-year median of 171.50. Over the past 10 years, this metric has ranged from a low of 117.07 to a high of 518.95. The Medical Devices & Instruments industry median Days Payable is 69.48. Sofwave Medical's value of 128.37 is 84.8% above this industry median. Based on the distribution chart, Sofwave Medical ranks #233 out of 797 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Sofwave Medical has a GF Score™ of 84/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sofwave Medical's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Sofwave Medical ranks #233 out of 797 companies for Days Payable. This puts Sofwave Medical in the upper half of its industry. The industry median Days Payable is 69.48. Sofwave Medical's value of 128.37 is 84.8% above this benchmark. Historically, Sofwave Medical's own Days Payable has ranged from 117.07 to 518.95 over the past decade. While the company's 10-year median is 171.50 vs. the industry median of 69.48, Sofwave Medical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 69.48, based on 797 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sofwave Medical's current Days Payable of 128.37 is 84.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Sofwave Medical and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 69.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sofwave Medical's current Days Payable is 128.37, which is 25% below median its own 10-year median of 171.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sofwave Medical stock overvalued right now?
Based on GuruFocus' analysis, Sofwave Medical (XTAE:SOFW) is currently considered Fairly Valued. The stock's GF Value™ is ₪33.26, compared to a current price of ₪32.49 — trading 2.3% below its estimated fair value. The current Days Payable is 128.37, which is 25% below median its 10-year median of 171.50 and 84.8% above the Medical Devices & Instruments industry median of 69.48. Sofwave Medical's overall GF Score™ is 84/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Sofwave Medical (XTAE:SOFW), the current Days Payable is 128.37 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sofwave Medical (XTAE:SOFW) Overvalued in 2026?
Based on GuruFocus' analysis, Sofwave Medical stock appears to be undervalued.
The current stock price of ₪32.49 is trading 2.3% below its estimated GF Value™ of ₪33.26.
GuruFocus considers Sofwave Medical to be Fairly Valued.
Key valuation signals for XTAE:SOFW:
Days Payable: 128.37 (25% below median its 10-year median of 171.50)
GF Value™: ₪33.26 vs. price of ₪32.49 (2.3% below fair value)
Industry Position: 84.8% above the Medical Devices & Instruments median (#233 of 797)
No single metric tells the full story. See the XTAE:SOFW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTAE:SOFW has been successfully added to your 
